Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
21 September 2018

The composition of the Council of the University of the Free State is stipulated in the UFS Statute, as promulgated in the Government Gazette of 26 January 2018. The terms of office of the President of Convocation, Prof Johan Grobbelaar, Christo Dippenaar, Henry Madlala (Qwaqwa Campus) expire on 31 October 2018. Convocation has to appoint three representatives in their place, one of which has to be the President of Convocation and another should be from the Qwaqwa Campus. In terms of the Statute, both Dippenaar and Madlala are eligible for re-election.
 
Written nominations for the election of three representatives of the Convocation for a period of four years, are hereby requested.
 
The Convocation comprises of all permanent academic staff from lecturer to professor, all permanent staff other than academic staff from Deputy Director to Rector and Vice-Chancellor by virtue of their respective offices and all students (current and former) who obtained a qualification at the university.
 
Each nomination shall be signed by five members of Convocation and shall contain the written acceptance of the nomination by the nominee under his or her signature, as well as an abridged CV (±2pages). These must reach Dawid Kriel by 12:00 on Monday 12 November 2018. If more than one person per each of the three categories is nominated, elections will be held on or before Friday 16 November 2018. You will be notified of the final date for elections in due course. Please submit your nomination via:
 
• E-mail: dawid@ufs.ac.za
• Fax: 086 643 1665
• Post: Dawid Kriel University of the Free State: Institutional Advancement PO Box 339 Bloemfontein 9300
• Hand delivered at: Dawid Kriel, Room 26, 1st Floor, Wekkie Saayman Building, Bloemfontein Campus
 
For enquiries, please contact Claudine Taylor at TaylorCL@ufs.ac.za or +27 51 401 2097.
 
Click here for the nominations form.

News Archive

Haemophilia home infusion workshop
2017-12-17


 Description: haemophilia Tags: Haemophilia, community, patient, clinical skills, training 

Parents receive training for homecare of their children with haemophilia.
Photo Supplied


Caregivers for haemophilia patients, and patients themselves from around the Free State and Northern Cape attended a home infusion workshop held by the Clinical Skills unit in the Faculty of Health Sciences in July 2017. “It felt liberating and I feel confident to give the factor to my son correctly,” said Amanda Chaba-Okeke, the mother of a young patient, at the workshop. Her son, also at the workshop, agreed. “It felt lovely and good to learn how to administer factor VIII.” 

Clinical skills to empower parents and communities

There were two concurrent sessions: one attended by doctors from the Haemophilia Treatment Centre, and the other attended by community members including factor VIII and XI recipients, caregivers and parents. The doctors’ meeting was shown informative videos and demonstrations on how to administer the newly devised factor VII and XI kit, and discussed the pressing need for trained nurses at local clinics. Dr Jaco Joubert, a haematologist, made an educational presentation to the community members.

The South African Haemophilia Foundation was represented by Mahlomola Sewolane, who gave a brief talk about the role of the organisation in relation to the condition. Meanwhile, procedural training in the simulation laboratory involved doctors and nurses helping participants to learn the procedures by using mannequins and even some volunteers from among the patients.

A medical condition causing serious complications
Haemophilia is a medical condition in which the ability of the blood to clot is severely impaired, even from a slight injury. The condition is typically caused by a hereditary lack of a coagulation factor, most often factor VIII. Usually patients must go through replacement therapy in which concentrates of clotting factor VIII (for haemophilia A) or clotting factor IX (for haemophilia B) are slowly dripped or injected into the vein, to help replace the clotting factor that is missing or low. Patients have to receive this treatment in hospital.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept